DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
down	TGM5; PPL; KRT33A; KRT34; KRT36; KRT37; KRT38; KRT75; KRT14; KRT6A; KRT6B; IVL; KRT19; KRT16; KRT3; KRT13; KRT5; KRT15; KRT4; SPRR1B; SPRR2E; SPRR2D; TGM1; CASP14; DSG3; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KRT6C; KRT76; DSG1; PKP1; KRT33B; KRT32; DSC3; KRT31; PRSS8; KRT24; LCE1A; LIPK; LIPM; KRT40; KRT80; SPINK6; RPTN; KRT27; KRT77; DSG4; CERS3; KRT78; EVPL; SPRR2F; LCE3D; SPRR2G; SPINK5; SPRR3; KLK12; KLK13; KLK5;	GO:0070268~cornification	61	113	53.9823008849557	0	0	0	0	0	0	0
down	HOXC11; BMP7; HOXA11; GDNF; ITGA8; FOXC2; SOX17; ROBO2;	GO:0001656~metanephros development	8	29	27.5862068965517	0.00010307813803389	0.00738566844842871	0.313254461485011	0.317583743282435	0.306863616926909	0.313254461485011	0.0635934668420786
down	EFNA2; NUDT3; C1QA; INHA; CGB7; FGF5; PTHLH; EDN3; NTF3; FGFR3; GJB2; GATA4; LHX1; EFNB3; TFAP2C; FGF14; GJB4; IL36G; TRHDE; CCL26; ADRA1D; ADRA2C; FGFBP1; ADRA1B;	GO:0007267~cell-cell signaling	24	230	10.4347826086957	0.00013732861584792	0.00940243256505428	0.417067006330134	0.423109465427443	0.399031129923627	0.417067006330134	0.0809585872606925
up	OR2A1; OR2A42; F2RL2; P2RY10; FCN1; GPR171; RGS13; RGS16; RGS5; ADCY5; OR2H2; S1PR4; F2; C3; CALCA; GHRH; PPBP; PF4; OPN1SW; CALCB; TRH; TBXA2R; HRH2; CXCR1; ACKR3; HTR2A; PTPN6; CXCR5; SSTR3; TRHR; VIPR2; CCR10; CXCL12; CCR6; PDE1A; NLRP6; CXCL6; RGS1; ADGRE1; GRM3; OR2B11; TAS2R42; OR2W3; GPR65; OR2L5; OR2AK2; OR56B2P; OR52N4; OR56B1; OR52I1; OR9A4; OR2T34; OR2L8; OR2T3; OR2L2; OR52I2; GPBAR1; PIK3R5; MCHR1; ADGRE3; OR10A4; PROK2; PDE7B; CYSLTR2; RASD1; PTGDR2; OR4D1; OR4E2; GNG11; OR1F2P; MRGPRF; GPR63; OR3A1; MRGPRD; OR5K2; OR3A4P; OR5B21; CCL7;	GO:0007186~G protein-coupled receptor signaling pathway	78	1152	6.77083333333333	0.00016544423607556	0.0599183874986996	0.35868310381182	0.359510324992197	0.358517659575744	0.35868310381182	0.495004357298419
down	ALDH1A3; MFAP2; FOXL2; EFEMP1; VAX2;	GO:0048048~embryonic eye morphogenesis	5	9	55.5555555555556	0.00016713752144803	0.0111945805126391	0.507429515116235	0.514950703581397	0.452274133038383	0.507429515116235	0.0963896754386459
down	LMX1B; HOXA11; HOXD11; LHX1; LHX2; FOXG1; EN1; OVOL2;	GO:0009953~dorsal/ventral pattern formation	8	32	25	0.0001841145260375	0.0118178511400323	0.558787586523826	0.567256854721551	0.479065996749586	0.558603471997788	0.101756277020282
down	MMP16; PRRX1; IRX5; DLX2; SIX1; GRHL2; SIX2; SIX4;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.0001841145260375	0.0118178511400323	0.558787586523826	0.567256854721551	0.479065996749586	0.558603471997788	0.101756277020282
down	CHL1; DSCAM; GLI2; BMP7; ANOS1; GDNF; LHX2; GBX2; GFRA1; WNT3A; TUBB3; VAX1; DPYSL5; ROBO2; FLRT3; NRXN3; EFNA2; EPHA3; LAMA1; LRTM1; EFNB3; EPHA6;	GO:0007411~axon guidance	22	206	10.6796116504854	0.00018955324464464	0.0119186438112277	0.574914991007214	0.584013546750157	0.487656670957632	0.574914991007214	0.102624140970355
down	HOXC11; FGF1; HOXA11; GDNF; SIX1;	GO:0001759~organ induction	5	10	50	0.00024225836370916	0.0140829814827915	0.734042842038782	0.74639801858795	0.561797145441563	0.733800583675073	0.12125992687284
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP4A22;	GO:0097267~omega-hydroxylase P450 pathway	5	10	50	0.00024225836370916	0.0140829814827915	0.734042842038782	0.74639801858795	0.561797145441563	0.733800583675073	0.12125992687284
down	CYP1A1; ADH1A; CYP2C9; UGT1A1; CYP2C19; FMO2; UGT1A7;	GO:0017144~drug metabolic process	7	25	28	0.00025893196168724	0.0145048977083347	0.784045979988986	0.79776937395841	0.582368534578957	0.783787048027299	0.12489278904186
down	ALOX12B; KRT16; SFN; FLG2; FA2H; TP63; GRHL1;	GO:0061436~establishment of skin barrier	7	25	28	0.00025893196168724	0.0145048977083347	0.784045979988986	0.79776937395841	0.582368534578957	0.783787048027299	0.12489278904186
down	HOXB1; HOXD10; HOXD3; SIX1; MDFI; ALX4; HOXD9; HOXD4; HOXC9;	GO:0048704~embryonic skeletal system morphogenesis	9	44	20.4545454545455	0.00027371353638949	0.0150591322431436	0.828257161114618	0.843311405616041	0.599432644692999	0.828257161114618	0.129664963119021
down	CDH3; CDH12; CDH11; CDH13; CDH6; CDH10; CDH8;	GO:0044331~cell-cell adhesion mediated by cadherin	7	27	25.9259259259259	0.00038529246259067	0.0208260715305588	1	1	0.706880266357114	0.999999988321173	0.179320544724847
down	TH; GLI2; WT1; PTN; EDNRA; APLNR; RIPPLY3; IRX4; FOXL1; NFATC4; RBM20; DNAH5; FOXC2; STRA6; FLRT3; PRICKLE4; SOX17; PDLIM3; SOX9; POPDC3;	GO:0007507~heart development	20	190	10.5263157894737	0.00042910064556522	0.0224147220968315	1	1	0.736840146349063	0.999999988321173	0.19299944160674
down	BMP7; SDC1; WT1; LHX1; SIX1; SFRP1; FOXC2; ROBO2;	GO:0001657~ureteric bud development	8	37	21.6216216216216	0.00043047500095883	0.0224147220968315	1	1	0.737622015218522	0.999999988321173	0.19299944160674
down	FOXE1; GLI2; TGM3; SOSTDC1; KRT27; FOXQ1; TP63;	GO:0031069~hair follicle morphogenesis	7	28	25	0.00046472004407682	0.0234721714065689	1	1	0.755427090692112	0.999999988321173	0.202104489861414
down	PAX7; LHX1; WNT3A; LHX5; LHX3;	GO:0021527~spinal cord association neuron differentiation	5	13	38.4615384615385	0.00062379378691335	0.0301253806450493	1	1	0.826150164819468	0.999999988321173	0.259391199122067
down	TBX3; CLDN7; EGFR; IGF2; KRT6A; FGF1; FGF5; PTHLH; EDN3; NTF3; EDN2; PTN; FGFR3; ADRA1D; SERPINB3; ALDH3A1; KDR; GDNF; CEACAM6; LIFR; ID4; SOX9; AKR1C2; WNT3A; BNC1; NRG1; EGR4; NTRK2; CCL14; NCCRP1; MYOCD; DYNAP; SFRP1; TFAP2B; HAS2; PDF; HOXC10; BTC;	GO:0008284~positive regulation of cell population proliferation	38	490	7.75510204081633	0.00063326388512108	0.0301253806450493	1	1	0.830208953393739	0.999999988321173	0.259391199122067
down	FMO2; CYP2F1; CYP2C19; CYP2W1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	6	21	28.5714285714286	0.0006551121399605	0.0301253806450493	1	1	0.839198651289402	0.999999988321173	0.259391199122067
down	CLDN7; CLDN8; CLDN17; CLDN18; CLDN10; CLDN16;	GO:0016338~calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules	6	21	28.5714285714286	0.0006551121399605	0.0301253806450493	1	1	0.839198651289402	0.999999988321173	0.259391199122067
down	CYP1A1; CYP2C9; CYP2C19; CYP4A11; CYP2F1; CYP2C18;	GO:0019373~epoxygenase P450 pathway	6	21	28.5714285714286	0.0006551121399605	0.0301253806450493	1	1	0.839198651289402	0.999999988321173	0.259391199122067
down	HOXD10; HOXC10; LHX3; MNX1;	GO:0021520~spinal cord motor neuron cell fate specification	4	7	57.1428571428571	0.00073006207170822	0.0321331606133292	1	1	0.870377561894282	0.999999988321173	0.276678962542609
down	ANXA8; SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	4	7	57.1428571428571	0.00073006207170822	0.0321331606133292	1	1	0.870377561894282	0.999999988321173	0.276678962542609
down	TBX3; GLI2; HOXD9; SOX9; WNT3A; NRG1;	GO:0030879~mammary gland development	6	22	27.2727272727273	0.00080510989169446	0.0344519941154257	1	1	0.900962880356634	0.999999988321173	0.296645017403797
down	KRT16; KRT3; KRT6C; EVPLL; PPL; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	6	22	27.2727272727273	0.00080510989169446	0.0344519941154257	1	1	0.900962880356634	0.999999988321173	0.296645017403797
down	HOXB1; LHX1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	4	8	50	0.00105968310218763	0.0420478750707904	1	1	0.965869854756101	0.999999988321173	0.362048495375264
down	AQP1; SCNN1B; SCNN1G; TRPV4;	GO:0050891~multicellular organismal water homeostasis	4	8	50	0.00105968310218763	0.0420478750707904	1	1	0.965869854756101	0.999999988321173	0.362048495375264
down	DKK1; C1QA; C1QB; C1QC;	GO:0098883~synapse pruning	4	8	50	0.00105968310218763	0.0420478750707904	1	1	0.965869854756101	0.999999988321173	0.362048495375264
down	TBX3; HOXD9; CRABP2; HOXA11; EN1; ALX4; TP63;	GO:0035115~embryonic forelimb morphogenesis	7	33	21.2121212121212	0.00107815064284078	0.0420478750707904	1	1	0.967727868481009	0.999999988321173	0.362048495375264
down	BMP7; SOX9; DLX1; DLX5; SFRP1; GATA6; GATA5;	GO:0071773~cellular response to BMP stimulus	7	33	21.2121212121212	0.00107815064284078	0.0420478750707904	1	1	0.967727868481009	0.999999988321173	0.362048495375264
up	BMP4; PTCH1; IL20; PTCH2;	GO:0045606~positive regulation of epidermal cell differentiation	4	8	50	0.00111647846554042	0.303263463202415	1	1	0.999999991993258	0.999999991993258	1
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00124407262107573	0.0479123468191791	1	1	0.984235192730624	0.999999988321173	0.412543869258017
down	IL20RB; IL36A; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	6	25	24	0.00141693697956535	0.0515279771946909	1	1	0.999999988321173	0.999999988321173	0.443675847629892
down	CYP2C9; CYP4B1; CYP2C19; CYP2W1; CYP2F1; CYP2C18;	GO:0042738~exogenous drug catabolic process	6	25	24	0.00141693697956535	0.0515279771946909	1	1	0.999999988321173	0.999999988321173	0.443675847629892
down	PLA2G4E; PLA2G4F; PLA2G4D; CYP2W1; GATA6; PLA2G3; PLPPR4; PLPPR5; PLA2G2F;	GO:0006644~phospholipid metabolic process	9	57	15.7894736842105	0.00142157678076882	0.0515279771946909	1	1	0.999999988321173	0.999999988321173	0.443675847629892
down	GABRD; GABRB2; FGF14; GRID1; GABRA3; GABRE; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	7	35	20	0.00145309056595655	0.0520578143454899	1	1	0.999999988321173	0.999999988321173	0.448237950778214
down	KRT6A; KRT16; SERPINB5; RIPK4; SOX9;	GO:0002009~morphogenesis of an epithelium	5	17	29.4117647058824	0.00167299350554029	0.0573440738147523	1	1	0.999999988321173	0.999999988321173	0.493754692915303
down	VIT; COL12A1; COL14A1; MATN3; VWA2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	5	17	29.4117647058824	0.00167299350554029	0.0573440738147523	1	1	0.999999988321173	0.999999988321173	0.493754692915303
down	EDN3; BTC; GDNF; SOX2; DLX1; DLX2; SOX17;	GO:0045597~positive regulation of cell differentiation	7	36	19.4444444444444	0.00167509465865878	0.0573440738147523	1	1	0.999999988321173	0.999999988321173	0.493754692915303
down	DKK1; NFATC4; NOTUM; SOSTDC1; SFRP1; MDFI; DKK4; WIF1;	GO:0030178~negative regulation of Wnt signaling pathway	8	47	17.0212765957447	0.00169475866518087	0.0573796862354096	1	1	0.999999988321173	0.999999988321173	0.494061329654827
up	F2; A2M; F11; SERPING1; GP5;	GO:0007597~blood coagulation, intrinsic pathway	5	17	29.4117647058824	0.00177945059629092	0.35152237688547	1	1	0.999999991993258	0.999999991993258	1
down	AGR2; PTN; VWC2; EGFLAM; EGFL6; SMOC2; VIT;	GO:0010811~positive regulation of cell-substrate adhesion	7	37	18.9189189189189	0.0019225718576017	0.0643852597094655	1	1	0.999999988321173	0.999999988321173	0.554382031503676
down	EDN2; MYOCD; NMU; ADRA1B; ADRA1D;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.00206631097277765	0.0663629053128611	1	1	0.999999988321173	0.999999988321173	0.571410326367316
down	GDNF; SOX9; LHX1; SIX1; SIX4;	GO:0090190~positive regulation of branching involved in ureteric bud morphogenesis	5	18	27.7777777777778	0.00206631097277765	0.0663629053128611	1	1	0.999999988321173	0.999999988321173	0.571410326367316
down	SOX1; DMRT3; LHX3;	GO:0021521~ventral spinal cord interneuron specification	3	4	75	0.00211086164253826	0.0663629053128611	1	1	0.999999988321173	0.999999988321173	0.571410326367316
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00211086164253826	0.0663629053128611	1	1	0.999999988321173	0.999999988321173	0.571410326367316
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00211086164253826	0.0663629053128611	1	1	0.999999988321173	0.999999988321173	0.571410326367316
down	GDNF; SIX1; SIX4;	GO:0072107~positive regulation of ureteric bud formation	3	4	75	0.00211086164253826	0.0663629053128611	1	1	0.999999988321173	0.999999988321173	0.571410326367316
down	SNAI2; ELN; GATA4; SOX9; GATA5; ROBO2;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.00233139135119886	0.0725557247782192	1	1	0.999999988321173	0.999999988321173	0.624732901308114
down	KLK8; EGFR; BMP7; WNT7B; NYAP1; NTF3; MNX1; DCLK1; NTF4;	GO:0048812~neuron projection morphogenesis	9	62	14.5161290322581	0.00238466195297304	0.0730665505390287	1	1	0.999999988321173	0.999999988321173	0.629131309022859
down	NR2E1; TFAP2B; SIX1; NR2F2; WIF1; SIX4; SIX2; TFAP2C;	GO:0048856~anatomical structure development	8	50	16	0.00239523583396362	0.0730665505390287	1	1	0.999999988321173	0.999999988321173	0.629131309022859
down	DKK1; BMP7; HOXD10; HOXA11; PRRX1; DLX5; HOXC10;	GO:0030326~embryonic limb morphogenesis	7	39	17.9487179487179	0.00250163674357018	0.073333487678049	1	1	0.999999988321173	0.999999988321173	0.631429741211866
down	DLX2; DLX3; DLX5; DLX4; DLX1;	GO:0009790~embryo development	5	19	26.3157894736842	0.00252299568123115	0.073333487678049	1	1	0.999999988321173	0.999999988321173	0.631429741211866
down	WNT3A; TCF15; SP5; HES7; TP63;	GO:0036342~post-anal tail morphogenesis	5	19	26.3157894736842	0.00252299568123115	0.073333487678049	1	1	0.999999988321173	0.999999988321173	0.631429741211866
down	KLK8; KRT2; CDH13; SDR16C5;	GO:0043616~keratinocyte proliferation	4	11	36.3636363636364	0.00264854805907477	0.0762633324299942	1	1	0.999999988321173	0.999999988321173	0.656656839664262
down	COL4A1; EDNRA; KDR; GBX2; NFATC4; FOXC2;	GO:0001569~branching involved in blood vessel morphogenesis	6	29	20.6896551724138	0.0027175992079107	0.0775270662923415	1	1	0.999999988321173	0.999999988321173	0.66753807783973
down	CASQ2; KRT19; SYNPO2L; MYOZ1; SIX4; MYOM3; TNNT2;	GO:0045214~sarcomere organization	7	40	17.5	0.00283719714352615	0.0801963706348997	1	1	0.999999988321173	0.999999988321173	0.690521822423608
down	SNAI2; GLI2; PTHLH; SOX9; EFEMP1;	GO:0032331~negative regulation of chondrocyte differentiation	5	20	25	0.0030486453858749	0.0846205084133386	1	1	0.999999988321173	0.999999988321173	0.728615362782544
down	PAX1; FGFR3; MMP13; SP5; HAS2; PAPPA2;	GO:0060349~bone morphogenesis	6	30	20	0.00314978506304397	0.0866472123146294	1	1	0.999999988321173	0.999999988321173	0.746066068598193
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.00327480218505949	0.0869798752773128	1	1	0.999999988321173	0.999999988321173	0.748930425593733
down	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.00327480218505949	0.0869798752773128	1	1	0.999999988321173	0.999999988321173	0.748930425593733
down	SOX18; NRG1; SOX17;	GO:0060956~endocardial cell differentiation	3	5	60	0.00327480218505949	0.0869798752773128	1	1	0.999999988321173	0.999999988321173	0.748930425593733
down	MYOCD; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.00327480218505949	0.0869798752773128	1	1	0.999999988321173	0.999999988321173	0.748930425593733
up	HPX; EPB42; AHSP;	GO:0020027~hemoglobin metabolic process	3	5	60	0.00340766132213499	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	ADH1B; ADH1C; ADH1A; ADH7;	GO:0006069~ethanol oxidation	4	12	33.3333333333333	0.00341789252752789	0.0892417531975714	1	1	0.999999988321173	0.999999988321173	0.768406070828444
down	CHRNB4; ATP1A2; CNN1; KCNB2;	GO:0006940~regulation of smooth muscle contraction	4	12	33.3333333333333	0.00341789252752789	0.0892417531975714	1	1	0.999999988321173	0.999999988321173	0.768406070828444
down	WT1; HOXA11; HOXD11; GDNF; SOX9; LHX1; SIX1;	GO:0001658~branching involved in ureteric bud morphogenesis	7	42	16.6666666666667	0.00361063959016694	0.0921489831036259	1	1	0.999999988321173	0.999999988321173	0.793438446695832
down	HOXC6; PAX7; DLX1; HOXC5; SULF1; DMRT2;	GO:0048706~embryonic skeletal system development	6	31	19.3548387096774	0.00363119352369734	0.0921489831036259	1	1	0.999999988321173	0.999999988321173	0.793438446695832
down	SNAI2; EDNRA; SOX9; NRG1; FOXC2;	GO:0014032~neural crest cell development	5	21	23.8095238095238	0.00364887242409684	0.0921489831036259	1	1	0.999999988321173	0.999999988321173	0.793438446695832
down	LMX1B; FOXA1; EN1; SFRP1; DMRTA2;	GO:0071542~dopaminergic neuron differentiation	5	21	23.8095238095238	0.00364887242409684	0.0921489831036259	1	1	0.999999988321173	0.999999988321173	0.793438446695832
down	HTR3B; SLC6A2; SLC6A1; GLRB; GRIN2A; PCDHB16; PCDHB10; PCDHB2; PCDHB13; PCDHB11; GABRA4; GABRP; GABRQ; GABRE; GABRB2; CHRNB4; NLGN4Y; NLGN1; GABRA3; HTR1D; GABRD;	GO:0007268~chemical synaptic transmission	21	249	8.43373493975904	0.00393956858800859	0.0978855711262457	1	1	0.999999988321173	0.999999988321173	0.842832692152484
down	MMP3; MMP10; COL15A1; MMP12; MMP13; KLK6; MMP16;	GO:0030574~collagen catabolic process	7	43	16.2790697674419	0.00405274143751044	0.0980934263443326	1	1	0.999999988321173	0.999999988321173	0.844622406111574
down	CDH3; CDH6; CDH8; CDH11; CDH12; CDH13; CDH10;	GO:0034332~adherens junction organization	7	43	16.2790697674419	0.00405274143751044	0.0980934263443326	1	1	0.999999988321173	0.999999988321173	0.844622406111574
down	CDH3; TGM1; HAS2; TP63;	GO:0010838~positive regulation of keratinocyte proliferation	4	13	30.7692307692308	0.00432611313650977	0.101746218118982	1	1	0.999999988321173	0.999999988321173	0.876074358527822
down	GABRB2; GABRA4; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	4	13	30.7692307692308	0.00432611313650977	0.101746218118982	1	1	0.999999988321173	0.999999988321173	0.876074358527822
down	EDNRA; LHX1; STRA6; FLRT3;	GO:0060322~head development	4	13	30.7692307692308	0.00432611313650977	0.101746218118982	1	1	0.999999988321173	0.999999988321173	0.876074358527822
down	SULT2B1; CYP1A1; CYP2C9; UGT1A1; CYP2C19; AKR1C2; UGT1A8;	GO:0008202~steroid metabolic process	7	44	15.9090909090909	0.00453462830476659	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	RAMP3; ALOX12B; DKK1; AGR2; APOB; MYCN; BMP7; WT1; CDH3; HOXD3; SOX9; WNT3A; LCN2; NRG1; SRY; CNTN1; PKP1; NTRK2; SLC26A9; SEC16B; OVOL2; GATA5; EPB41L4B; TRPV4; IL1F10; IL36A; IL36G; IL36B;	GO:0010628~positive regulation of gene expression	28	374	7.48663101604278	0.00474258283929385	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	DCN; BGN; EGFLAM;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	SOX1; GBX2; LHX6;	GO:0021884~forebrain neuron development	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	SOX9; DLX1; DLX2;	GO:0046533~negative regulation of photoreceptor cell differentiation	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	BMP7; HOXD13; SFRP1;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	C1QL1; DKK1; EN1;	GO:0061743~motor learning	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	SOX9; LHX1; EMX2;	GO:0072197~ureter morphogenesis	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	GJB6; GJB2; GJB4;	GO:1990349~gap junction-mediated intercellular transport	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	OVOL1; SNAI2; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	3	6	50	0.00476333563409204	0.104083950983245	1	1	0.999999988321173	0.999999988321173	0.896203144219631
down	PPL; SCEL; DCN; GATA4; BDKRB1; POSTN; PIEZO2; TRPV4;	GO:0009612~response to mechanical stimulus	8	57	14.0350877192982	0.00490787600963116	0.105742419480235	1	1	0.999999988321173	0.999999988321173	0.910483200535237
down	DLX3; GLI2; BMP7; DLX1; DLX2; AMTN; SOSTDC1; TP63;	GO:0042475~odontogenesis of dentin-containing tooth	8	57	14.0350877192982	0.00490787600963116	0.105742419480235	1	1	0.999999988321173	0.999999988321173	0.910483200535237
up	IFNG; FCER2; PRF1;	GO:0051712~positive regulation of killing of cells of other organism	3	6	50	0.00495442523804424	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	PTN; NFATC4; NTRK2; NLGN1; SHANK2; NR2E1; GRIN2A;	GO:0060291~long-term synaptic potentiation	7	45	15.5555555555556	0.00505847944537596	0.107483966697954	1	1	0.999999988321173	0.999999988321173	0.925478596824315
down	FUT3; MGAT2; ST6GALNAC5; B3GALT5;	GO:0009312~oligosaccharide biosynthetic process	4	14	28.5714285714286	0.00538391866500643	0.109951807553911	1	1	0.999999988321173	0.999999988321173	0.946727662733603
down	ALDH1A3; CYP27C1; SDR16C5; BCO1;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.00538391866500643	0.109951807553911	1	1	0.999999988321173	0.999999988321173	0.946727662733603
down	AGR2; EGFR; SFRP1; STRA6;	GO:0048546~digestive tract morphogenesis	4	14	28.5714285714286	0.00538391866500643	0.109951807553911	1	1	0.999999988321173	0.999999988321173	0.946727662733603
down	SCNN1B; SCNN1G; CYP4A11; TFAP2B;	GO:0055078~sodium ion homeostasis	4	14	28.5714285714286	0.00538391866500643	0.109951807553911	1	1	0.999999988321173	0.999999988321173	0.946727662733603
down	RAMP3; MMP3; MMP12; MMP13;	GO:1904645~response to amyloid-beta	4	14	28.5714285714286	0.00538391866500643	0.109951807553911	1	1	0.999999988321173	0.999999988321173	0.946727662733603
down	BMP7; PAX7; HOXD3; SOX9; LUM; PRRX1; DLX2; SULF1;	GO:0051216~cartilage development	8	58	13.7931034482759	0.00538874486875707	0.109951807553911	1	1	0.999999988321173	0.999999988321173	0.946727662733603
down	GJB6; C1QB; GJB2; SOX2; SIX1; PLPPR4; LHX3;	GO:0048839~inner ear development	7	46	15.2173913043478	0.00562649241788282	0.114047520654585	1	1	0.999999988321173	0.999999988321173	0.981993339372233
up	CD3D; LCK; EGR1; DLL4; TBX21; CD3G;	GO:0030217~T cell differentiation	6	34	17.6470588235294	0.00577870152545867	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	OOEP; NCKAP5; KRT36; BGN; CRYBA2; RIPPLY3; KRTDAP; RAD51AP2; TMEM132B; KRT24; EXOC3L2; PRICKLE4; TMEM35A; HIST2H2AA3; GGT6; SBSN; C5orf46; C6orf15; IGFL3; PTCHD4; KRT27; KRT77; TMPRSS11B; UNC93A; IL22RA1; TMEM54; CYYR1; HIST1H2AH; TMEM47; GPR87; GSDMC; PRRG3; PLA2G2F; POPDC3; CCM2L; EPHA6; FETUB; PSORS1C2; DMRT2; LINC01558;	GO:0008150~biological_process	40	603	6.6334991708126	0.0062594976824516	0.126049100389761	1	1	0.999999988321173	0.999999988321173	1
up	PF4; CORO1A; CXCR5; PPBP; CXCL6;	GO:0030595~leukocyte chemotaxis	5	24	20.8333333333333	0.00631052386528097	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	WT1; APLNR; SOX18; KDR; NTRK2; MYOCD; HAS2; SOX17;	GO:0001570~vasculogenesis	8	60	13.3333333333333	0.00645737684830328	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	CYP1A1; TH; LCN2;	GO:0009635~response to herbicide	3	7	42.8571428571429	0.00659899392804153	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.00659899392804153	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	FOXP2; ALDH1A3; GLRB;	GO:0060013~righting reflex	3	7	42.8571428571429	0.00659899392804153	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	SOX9; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	3	7	42.8571428571429	0.00659899392804153	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	WT1; FOXC2; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.00659899392804153	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.00659899392804153	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
down	HOXA11; LHX1; FOXL2; MYOCD;	GO:0060065~uterus development	4	15	26.6666666666667	0.00660145065341355	0.126329623994827	1	1	0.999999988321173	0.999999988321173	1
up	TMOD1; LMOD3; LMOD2;	GO:0051694~pointed-end actin filament capping	3	7	42.8571428571429	0.00686074779881118	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	DEFB4A; KRT6A; S100A7; H2BFS; DEFB1; PGLYRP4; PGLYRP3; RNASE7;	GO:0061844~antimicrobial humoral immune response mediated by antimicrobial peptide	8	62	12.9032258064516	0.00767914228056998	0.146045909669359	1	1	0.999999988321173	0.999999988321173	1
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036152~phosphatidylethanolamine acyl-chain remodeling	5	26	19.2307692307692	0.00796230727862035	0.146498411414251	1	1	0.999999988321173	0.999999988321173	1
down	MIF; EDN2; PTGIS; PLA2G4F;	GO:0001516~prostaglandin biosynthetic process	4	16	25	0.00798822885997863	0.146498411414251	1	1	0.999999988321173	0.999999988321173	1
down	ASTN1; NLGN1; NLGN4Y; NRXN3;	GO:0007158~neuron cell-cell adhesion	4	16	25	0.00798822885997863	0.146498411414251	1	1	0.999999988321173	0.999999988321173	1
down	EDN3; EDN2; ATP1A2; ACE2;	GO:0019229~regulation of vasoconstriction	4	16	25	0.00798822885997863	0.146498411414251	1	1	0.999999988321173	0.999999988321173	1
down	EDN3; EDN2; EDNRA; HTR1D;	GO:0042310~vasoconstriction	4	16	25	0.00798822885997863	0.146498411414251	1	1	0.999999988321173	0.999999988321173	1
up	TYROBP; CTLA4; MNDA; CD300A;	GO:0030889~negative regulation of B cell proliferation	4	16	25	0.00838548837739617	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	3	8	37.5	0.00879984337417539	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	SFRP1; MDFI; VAX2;	GO:0009950~dorsal/ventral axis specification	3	8	37.5	0.00879984337417539	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	HOXD9; HOXD10; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.00879984337417539	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	WT1; SIX1; SIX4;	GO:0072075~metanephric mesenchyme development	3	8	37.5	0.00879984337417539	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	WT1; SOX9; SRY;	GO:2000020~positive regulation of male gonad development	3	8	37.5	0.00879984337417539	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036151~phosphatidylcholine acyl-chain remodeling	5	27	18.5185185185185	0.00912492549562316	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	TH; EN1; NLGN4Y; GRID1; SHANK2; NR2E1; NRXN3;	GO:0035176~social behavior	7	51	13.7254901960784	0.00920650291401193	0.149922454136639	1	1	0.999999988321173	0.999999988321173	1
down	SNAI2; CEACAM5; CEACAM6; NTRK2;	GO:2000811~negative regulation of anoikis	4	17	23.5294117647059	0.00955310799233722	0.150169008797913	1	1	0.999999988321173	0.999999988321173	1
up	LILRA5; ANK2; LILRA2; ORAI1; MCHR1;	GO:0051928~positive regulation of calcium ion transport	5	27	18.5185185185185	0.00965985186495466	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	DEFB4A; S100A7; PRSS3; DEFB1; LCN2; PGLYRP3; RNASE7;	GO:0019730~antimicrobial humoral response	7	52	13.4615384615385	0.0100859823726366	0.156943998434815	1	1	0.999999988321173	0.999999988321173	1
down	COBL; CYP1A1; CLDN18; MYOCD; ALX4;	GO:0048565~digestive tract development	5	28	17.8571428571429	0.0103993832383935	0.161007536469801	1	1	0.999999988321173	0.999999988321173	1
down	TBX3; SNAI2; MEOX2; PRRX1; DLX5; FOXF2; VAX1; ALX4;	GO:0060021~roof of mouth development	8	66	12.1212121212121	0.0106334247787938	0.163807908717319	1	1	0.999999988321173	0.999999988321173	1
down	EFNA2; LHX2; DLX2; NR2E1;	GO:0021772~olfactory bulb development	4	18	22.2222222222222	0.011304244544963	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	GLI2; BMP7; EN2; GBX2;	GO:0030902~hindbrain development	4	18	22.2222222222222	0.011304244544963	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	PLA2G4F; PLA2G4D; PLA2G2F; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	4	18	22.2222222222222	0.011304244544963	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	BMP7; RIPPLY3; SIX1; SIX4;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.011304244544963	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	APOB; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	3	9	33.3333333333333	0.0113798967981744	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	GATA4; GATA6; GATA5;	GO:0060575~intestinal epithelial cell differentiation	3	9	33.3333333333333	0.0113798967981744	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	FGF1; PTN; WNT3A;	GO:2000347~positive regulation of hepatocyte proliferation	3	9	33.3333333333333	0.0113798967981744	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	WNT3A; NRG1; MYOCD;	GO:2000727~positive regulation of cardiac muscle cell differentiation	3	9	33.3333333333333	0.0113798967981744	0.168564721322959	1	1	0.999999988321173	0.999999988321173	1
down	PTPRZ1; NKX6-1; NRG1; NTRK2; SOX9;	GO:0048709~oligodendrocyte differentiation	5	29	17.2413793103448	0.0117904163224241	0.173809917174108	1	1	0.999999988321173	0.999999988321173	1
up	TYROBP; IFNG; EGR1;	GO:0050725~positive regulation of interleukin-1 beta biosynthetic process	3	9	33.3333333333333	0.0118211032835286	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	FAM107A; APOD; ACVRL1; DLC1;	GO:0051895~negative regulation of focal adhesion assembly	4	18	22.2222222222222	0.0118556997703643	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	KLK8; TH; PTN; ITGA8; GRIN2A; ADGRF1; PAK5; NTF3; NTF4;	GO:0007613~memory	9	83	10.8433734939759	0.0130342577842234	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	RASSF10; CHL1; TOM1L1; RASSF9; EGFR; GAST; INHA; FGF1; CGB7; SCGB1A1; EDN3; NTF3; ENDOU; ITPKA; NR2F2; EDNRA; CRABP2; CHRNB4; NTS; SFN; BTC; COL15A1; GDNF; CAP2; CEACAM6; SOX9; PRKAA2; FAM3B; GNGT1; PKP1; GRB14; FGFBP1; ARHGAP40; CASKIN1; CDS1; FGF14; FAM3D; SH3GL3; DPYSL5; RERGL; CALML5; PAK5; ARHGAP28; TRHDE; CCL26; WIF1; GABRD; GABRQ; GABRE; HTR3B; GLRB; GABRA3; GABRA4; PLPPR4; CBLC; GABRP; GABRB2; PLPPR5;	GO:0007165~signal transduction	58	989	5.86450960566229	0.0130467805989851	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	TBX3; HOXC11; GLI2; HOXA11; HOXD13; GRHL2; ALX4;	GO:0042733~embryonic digit morphogenesis	7	55	12.7272727272727	0.0130906233385781	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	NR2E1; WNT7B; GATA5; GATA6; WNT3A; SOX2; GATA4;	GO:0045165~cell fate commitment	7	55	12.7272727272727	0.0130906233385781	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	DKK1; ADH7; LYPD6; GPIHBP1; LYPD1; DKK4;	GO:2000272~negative regulation of signaling receptor activity	6	42	14.2857142857143	0.0131141751884442	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	ALOX12B; TH; PSAPL1; ACER1;	GO:0006665~sphingolipid metabolic process	4	19	21.0526315789474	0.0132490726654184	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036149~phosphatidylinositol acyl-chain remodeling	4	19	21.0526315789474	0.0132490726654184	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	NTF4; GABRB2; SULF1; SLITRK6;	GO:0060384~innervation	4	19	21.0526315789474	0.0132490726654184	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
down	OVOL1; LHX2; TCF15; FOXC2; HES7;	GO:0007498~mesoderm development	5	30	16.6666666666667	0.0133025525082391	0.188005340724241	1	1	0.999999988321173	0.999999988321173	1
up	CD160; HLA-G; CD40LG; CD248;	GO:2000353~positive regulation of endothelial cell apoptotic process	4	19	21.0526315789474	0.0138891637339447	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	IFNG; APOD; IGFBP5; VIPR2; AIF1;	GO:0048662~negative regulation of smooth muscle cell proliferation	5	30	16.6666666666667	0.0140628099780316	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	EDN3; EDN2; EDNRA;	GO:0014824~artery smooth muscle contraction	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	PAX7; FOXA1; WNT3A;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	TBX3; HOXD10; TFAP2B;	GO:0035136~forelimb morphogenesis	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	TCF15; SHROOM2; STRA6;	GO:0043583~ear development	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	HOXD9; HOXD10; NTRK2;	GO:0048935~peripheral nervous system neuron development	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	HOXC11; BMP7; HOXA11;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	SLURP1; LYPD6; LYPD6B;	GO:0099601~regulation of neurotransmitter receptor activity	3	10	30	0.0143494960199819	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
up	CCDC40; DRC1; CCDC65;	GO:0070286~axonemal dynein complex assembly	3	10	30	0.0148994653710307	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	EGFR; EDNRA; NTF4; ADCYAP1R1; NTRK2;	GO:0007202~activation of phospholipase C activity	5	31	16.1290322580645	0.0149400956444228	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	GLI2; HOXB1; LHX1; SIX1; SOSTDC1;	GO:0007389~pattern specification process	5	31	16.1290322580645	0.0149400956444228	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
up	IL2RA; CTLA4; HLA-G; PTPN6; LILRB2; MAD1L1;	GO:0042130~negative regulation of T cell proliferation	6	43	13.953488372093	0.015376662806263	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	EDN3; EDN2; NMU; RGS4;	GO:0010460~positive regulation of heart rate	4	20	20	0.0153942880622855	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	FOXN1; COL4A1; NR2F2; LAMA1;	GO:0048514~blood vessel morphogenesis	4	20	20	0.0153942880622855	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	CDH11; WNT3A; NLGN1; NTF3; NLGN4Y; NTF4; GRIN2A; GRID1;	GO:0050804~modulation of chemical synaptic transmission	8	71	11.2676056338028	0.0154157015927495	0.189226201622555	1	1	0.999999988321173	0.999999988321173	1
down	SLC6A15; SLC6A14; SLC6A1; SLC6A2; SLC6A11;	GO:0006810~transport	5	32	15.625	0.0167071116008635	0.201861218989256	1	1	0.999999988321173	0.999999988321173	1
down	SCNN1B; SCNN1G; UGT1A7; ATP6V0A4; CLDN16;	GO:0007588~excretion	5	32	15.625	0.0167071116008635	0.201861218989256	1	1	0.999999988321173	0.999999988321173	1
down	FGF1; ADRA2C; NTF3; NRG1; DYNAP;	GO:0032148~activation of protein kinase B activity	5	32	15.625	0.0167071116008635	0.201861218989256	1	1	0.999999988321173	0.999999988321173	1
down	ASTN1; DSCAM; C1QL1; TH; CHRNB4; ALDH1A3; SLURP1; NRG1; PAK5;	GO:0007626~locomotory behavior	9	87	10.3448275862069	0.0168557169426289	0.202861187110311	1	1	0.999999988321173	0.999999988321173	1
down	PLA2G4E; PLA2G4F; PLA2G4D; PLA2G2F;	GO:0036150~phosphatidylserine acyl-chain remodeling	4	21	19.047619047619	0.017745839048241	0.210288192721656	1	1	0.999999988321173	0.999999988321173	1
down	KDR; FGFBP1; FOXC2; RHOJ;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	4	21	19.047619047619	0.017745839048241	0.210288192721656	1	1	0.999999988321173	0.999999988321173	1
down	NLGN1; SHANK2; SHISA9; SHISA6;	GO:2000311~regulation of AMPA receptor activity	4	21	19.047619047619	0.017745839048241	0.210288192721656	1	1	0.999999988321173	0.999999988321173	1
down	SDC1; AQP1; AQP5; PAX9; PITX2;	GO:0042476~odontogenesis	5	33	15.1515151515152	0.0186074159518845	0.219653059569947	1	1	0.999999988321173	0.999999988321173	1
down	CIDEA; EDN2; ACADL; NMU;	GO:0001659~temperature homeostasis	4	22	18.1818181818182	0.0203089238890179	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	BMP7; LHX1; SIM2; RIPPLY3;	GO:0009880~embryonic pattern specification	4	22	18.1818181818182	0.0203089238890179	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	REN; CYP1A1; TH; GAL;	GO:0035902~response to immobilization stress	4	22	18.1818181818182	0.0203089238890179	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	PTN; TM4SF4; SOX2; KLK6;	GO:0042246~tissue regeneration	4	22	18.1818181818182	0.0203089238890179	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	RASSF10; LHX2; WNT3A; NR2E1;	GO:2000179~positive regulation of neural precursor cell proliferation	4	22	18.1818181818182	0.0203089238890179	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
up	CXCL14; PDGFRA; CXCL12; CCR6; ACKR3; CXCR5; CCR10; CXCR1;	GO:0060326~cell chemotaxis	8	74	10.8108108108108	0.0204052030098079	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	OVOL1; KRT9; TCF15; DACT2; TFAP2B;	GO:0043588~skin development	5	34	14.7058823529412	0.0206445633667516	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	DKK1; DLX1; HTRA3; VWC2; SOSTDC1; SFRP1;	GO:0030514~negative regulation of BMP signaling pathway	6	47	12.7659574468085	0.0206753604687293	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	IGF2; FGF1; FGF5; PTN; BTC; GKN1;	GO:0051781~positive regulation of cell division	6	47	12.7659574468085	0.0206753604687293	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	HOXD9; HOXD10; HOXA11; FOXL2; IZUMO1; FETUB; TRPC6;	GO:0007338~single fertilization	7	61	11.4754098360656	0.0209341700414657	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
up	SLIT2; SERPINF1; ACVRL1; DLL4;	GO:0010596~negative regulation of endothelial cell migration	4	22	18.1818181818182	0.0212616422455013	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	LILRA5; IFNG; ORM2; LILRA2;	GO:1904469~positive regulation of tumor necrosis factor secretion	4	22	18.1818181818182	0.0212616422455013	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	DKK1; LHX1; SOX17;	GO:0001706~endoderm formation	3	12	25	0.021482446150908	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	SOX18; PDPN; FOXC2;	GO:0001946~lymphangiogenesis	3	12	25	0.021482446150908	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	EDN3; EDN2; PTN;	GO:0002690~positive regulation of leukocyte chemotaxis	3	12	25	0.021482446150908	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	ADAMTS9; FBXO17; NCCRP1;	GO:0006516~glycoprotein catabolic process	3	12	25	0.021482446150908	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	ATP12A; ATP6V0A4; RHCG;	GO:0006885~regulation of pH	3	12	25	0.021482446150908	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	WNT3A; EMX2; LHX5;	GO:0021846~cell proliferation in forebrain	3	12	25	0.021482446150908	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
up	TMOD1; LMOD3; LMOD2;	GO:0030239~myofibril assembly	3	12	25	0.0222868784539123	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	IL2RA; CTLA4; HLA-G;	GO:0050777~negative regulation of immune response	3	12	25	0.0222868784539123	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	VCAM1; CD40LG; CORO1A; AIF1; NCKAP1L; CLECL1; LILRB2;	GO:0042102~positive regulation of T cell proliferation	7	61	11.4754098360656	0.0223970234579038	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	FOXP2; PTN; LHX1; EN1; CNTN1; GBX2;	GO:0021549~cerebellum development	6	48	12.5	0.0224796708114601	0.22341892183906	1	1	0.999999988321173	0.999999988321173	1
down	EGFR; NRG1; GRIN2A; CYP51A1; SERPINB12;	GO:0042177~negative regulation of protein catabolic process	5	35	14.2857142857143	0.0228218386485592	0.226090305068203	1	1	0.999999988321173	0.999999988321173	1
down	SMIM22; EPHA3; FZD10; ARHGAP40; RHOJ; RND3; ARHGAP28; RHOD;	GO:0032956~regulation of actin cytoskeleton organization	8	77	10.3896103896104	0.0230062494487211	0.226541747078965	1	1	0.999999988321173	0.999999988321173	1
down	GLI2; HOXA11; DMBX1; STRA6;	GO:0048589~developmental growth	4	23	17.3913043478261	0.0230879936977588	0.226541747078965	1	1	0.999999988321173	0.999999988321173	1
down	APOB; PRRX1; FOXC2; STRA6;	GO:0048844~artery morphogenesis	4	23	17.3913043478261	0.0230879936977588	0.226541747078965	1	1	0.999999988321173	0.999999988321173	1
up	VSTM1; CD300LF; CTLA4; IRF8; IRF4;	GO:0002376~immune system process	5	35	14.2857142857143	0.0240709467661386	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	FOLR1; SOX18; GATA4; WNT3A; OVOL2; SOX17; TBX3;	GO:0001947~heart looping	7	63	11.1111111111111	0.0241489036933651	0.23545181101031	1	1	0.999999988321173	0.999999988321173	1
down	CYP1A1; TH; CYP4A11; PLA2G4D; UGT1A8; CYP4F11; FA2H;	GO:0006631~fatty acid metabolic process	7	63	11.1111111111111	0.0241489036933651	0.23545181101031	1	1	0.999999988321173	0.999999988321173	1
up	TNFSF11; FOS; IFNG; IL20;	GO:0045672~positive regulation of osteoclast differentiation	4	23	17.3913043478261	0.0241603932178265	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	FCN1; C1R; CFD; C3; C2; CFH; C1S; C4A; C4B;	GO:0006956~complement activation	9	92	9.78260869565217	0.0245735460602755	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	GLRB; GRIN2A; SLITRK6;	GO:0001964~startle response	3	13	23.0769230769231	0.0256511892948126	0.246972856929117	1	1	0.999999988321173	0.999999988321173	1
down	ID4; DLX1; DLX2;	GO:0048715~negative regulation of oligodendrocyte differentiation	3	13	23.0769230769231	0.0256511892948126	0.246972856929117	1	1	0.999999988321173	0.999999988321173	1
down	NFATC4; MYOCD; GATA6;	GO:0051145~smooth muscle cell differentiation	3	13	23.0769230769231	0.0256511892948126	0.246972856929117	1	1	0.999999988321173	0.999999988321173	1
down	WNT3A; NLGN1; NLGN4Y;	GO:0099054~presynapse assembly	3	13	23.0769230769231	0.0256511892948126	0.246972856929117	1	1	0.999999988321173	0.999999988321173	1
down	TBX3; SOX9; SOSTDC1; ANKRD2;	GO:0045662~negative regulation of myoblast differentiation	4	24	16.6666666666667	0.0260867601820307	0.24960654695912	1	1	0.999999988321173	0.999999988321173	1
down	GLI2; SOX9; SIX1; MYO3A;	GO:0090103~cochlea morphogenesis	4	24	16.6666666666667	0.0260867601820307	0.24960654695912	1	1	0.999999988321173	0.999999988321173	1
down	EGFR; BTC; SOX9; EFEMP1; FAM83B; FAM83A;	GO:0007173~epidermal growth factor receptor signaling pathway	6	50	12	0.0263992266449508	0.251814295025057	1	1	0.999999988321173	0.999999988321173	1
up	SERPING1; ACVRL1; CXCL12; NFE2; DLL4;	GO:0008015~blood circulation	5	36	13.8888888888889	0.0265063312441158	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	CFD; C3; CFH;	GO:0006957~complement activation, alternative pathway	3	13	23.0769230769231	0.0266005222019481	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	GHRH; WNT1; IGFBP5;	GO:0043568~positive regulation of insulin-like growth factor receptor signaling pathway	3	13	23.0769230769231	0.0266005222019481	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	DEFB4A; KRT6A; H2BFS; DEFB1; LCE3A; PGLYRP4; PGLYRP3; RNASE7; GBP6;	GO:0050830~defense response to Gram-positive bacterium	9	95	9.47368421052632	0.0268491165568617	0.255315210221269	1	1	0.999999988321173	0.999999988321173	1
up	TRGV4; TRDV1; TRDV2; LILRA5; CD300LB; TYROBP; CD160; C1R; TRGV3; SERPING1; C2; C1S; C4A; C4B; CORO1A; KIR2DS4; NLRP6; SIGLEC14; SLAMF1; CD300E; TNFAIP8L2; TREML1; LILRA2; CLEC4C; KLRG1; CD180; TRGV9; CD84; IGHV3-35; TRBC1; TRBC2; IGHD;	GO:0045087~innate immune response	32	505	6.33663366336634	0.0270953542166439	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	DLL1; CXCL14; BMP4; SOX8;	GO:0045662~negative regulation of myoblast differentiation	4	24	16.6666666666667	0.027286423193673	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	STC2; PTN; GJB2; PTGIS;	GO:0046697~decidualization	4	25	16	0.0293082076087975	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	SNAI2; SFN; SLURP1;	GO:0010839~negative regulation of keratinocyte proliferation	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	DCN; BGN; HYAL4;	GO:0030207~chondroitin sulfate catabolic process	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	PRKAA2; LCN2; UCN2;	GO:0031669~cellular response to nutrient levels	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	BTC; TFAP2B; HAS2;	GO:0035810~positive regulation of urine volume	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	SIX1; TFAP2B; ADAMTS9;	GO:0035909~aorta morphogenesis	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	GHR; FOXA1; KLK6;	GO:0042445~hormone metabolic process	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	SAA1; EDN2; CXCL17;	GO:0048246~macrophage chemotaxis	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	FOXP2; ITGA8; STRA6;	GO:0048745~smooth muscle tissue development	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	GJB5; NR2F2; MDFI;	GO:0060707~trophoblast giant cell differentiation	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	SOX2; LUM; GATA6;	GO:0070848~response to growth factor	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
down	COBL; BMP7; PTN;	GO:1900006~positive regulation of dendrite development	3	14	21.4285714285714	0.0302208484715399	0.262590672250576	1	1	0.999999988321173	0.999999988321173	1
up	WNT1; TUBB2B; RNF112;	GO:1990403~embryonic brain development	3	14	21.4285714285714	0.0313261774151803	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	DCN; BGN; CHSY3; CHST9;	GO:0030206~chondroitin sulfate biosynthetic process	4	26	15.3846153846154	0.0327546084113802	0.278776100871443	1	1	0.999999988321173	0.999999988321173	1
down	SNAI2; TH; KRT76; EN1;	GO:0043473~pigmentation	4	26	15.3846153846154	0.0327546084113802	0.278776100871443	1	1	0.999999988321173	0.999999988321173	1
down	SIX1; NLGN1; NTF3; NTF4;	GO:0045664~regulation of neuron differentiation	4	26	15.3846153846154	0.0327546084113802	0.278776100871443	1	1	0.999999988321173	0.999999988321173	1
down	CASQ2; ABCC9; NPPC; ATP1A2; FXYD3; ACE2;	GO:1903779~regulation of cardiac conduction	6	53	11.3207547169811	0.0330859074027018	0.280820057046072	1	1	0.999999988321173	0.999999988321173	1
up	IFNG; HLA-G; CD40LG; IRF8;	GO:0032735~positive regulation of interleukin-12 production	4	26	15.3846153846154	0.0342309132948619	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	CALCA; F2RL2; GPR65; P2RY10; GPR174;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	5	39	12.8205128205128	0.0347308538996263	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	CD160; LCK; CTLA4; PTPN6; CD40LG; ICOS;	GO:0031295~T cell costimulation	6	53	11.3207547169811	0.0350684818363691	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	SOX18; FOXC2; SOX17;	GO:0035050~embryonic heart tube development	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	KRT14; KRT16; KRT33B;	GO:0042633~hair cycle	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	PLA2G4D; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	GDNF; TFAP2B; TP63;	GO:0048485~sympathetic nervous system development	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	TH; BMP7; FOXF2;	GO:0048596~embryonic camera-type eye morphogenesis	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	SERPINB5; SIX1; SIX4;	GO:0050678~regulation of epithelial cell proliferation	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	LAMA1; SOX9; FOXA1;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	NLGN4Y; SHANK2; NRXN3;	GO:0071625~vocalization behavior	3	15	20	0.0351882344328835	0.291438038407834	1	1	0.999999988321173	0.999999988321173	1
down	SNAI2; BMP7; SOX9; FOXF2; FAM83D;	GO:0001837~epithelial to mesenchymal transition	5	40	12.5	0.0359054075323291	0.296580591439962	1	1	0.999999988321173	0.999999988321173	1
down	GABRB2; GABRA4; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	4	27	14.8148148148148	0.036427541912518	0.299288684353248	1	1	0.999999988321173	0.999999988321173	1
down	GAL; ADCYAP1R1; SOX9; DEFB1;	GO:0019933~cAMP-mediated signaling	4	27	14.8148148148148	0.036427541912518	0.299288684353248	1	1	0.999999988321173	0.999999988321173	1
up	SLIT2; BMP4; HEYL;	GO:0003184~pulmonary valve morphogenesis	3	15	20	0.0364600514402019	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	IFNG; IL2RA; CTLA4;	GO:0045589~regulation of regulatory T cell differentiation	3	15	20	0.0364600514402019	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	TESPA1; LCK; TRAT1;	GO:0050862~positive regulation of T cell receptor signaling pathway	3	15	20	0.0364600514402019	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	PTPN6; CORO1A; ANK2;	GO:0051279~regulation of release of sequestered calcium ion into cytosol	3	15	20	0.0364600514402019	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	BMP4; HOXA5; RSPO2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	3	15	20	0.0364600514402019	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	ACKR3; CXCL12; CDKN2D;	GO:1902230~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage	3	15	20	0.0364600514402019	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	PSG1; SCGB1A1; PTHLH; ADRA2C; ENDOU; PSG4; PSG6; PSG7;	GO:0007565~female pregnancy	8	86	9.30232558139535	0.0387968935551047	0.305825449849791	1	1	0.999999988321173	0.999999988321173	1
up	TNFSF11; CCR6; RCAN2; PTGDR2; CCR10; CXCR5; ACKR3; CXCR1;	GO:0019722~calcium-mediated signaling	8	85	9.41176470588235	0.0393960192914488	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	ATP13A5; ANO1; PIEZO2; TRPC6;	GO:0006812~cation transport	4	28	14.2857142857143	0.0403279156863519	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	SHANK2; ADRA1D; ADRA1B; ADRA2C;	GO:0007610~behavior	4	28	14.2857142857143	0.0403279156863519	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	DACT2; GRHL2; POF1B;	GO:0003382~epithelial cell morphogenesis	3	16	18.75	0.0405482563915077	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	CSTB; SERPINB3; SERPINB4;	GO:0010466~negative regulation of peptidase activity	3	16	18.75	0.0405482563915077	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	ALOX12B; PON3; PLA2G3;	GO:0019372~lipoxygenase pathway	3	16	18.75	0.0405482563915077	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	AQP1; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	3	16	18.75	0.0405482563915077	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	GLI2; FOXF2; STRA6;	GO:0048566~embryonic digestive tract development	3	16	18.75	0.0405482563915077	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
down	FOXA1; SIX1; DMRTA2;	GO:0048665~neuron fate specification	3	16	18.75	0.0405482563915077	0.306198965544694	1	1	0.999999988321173	0.999999988321173	1
up	NCAM2; NLGN4X; NINJ2;	GO:0007158~neuron cell-cell adhesion	3	16	18.75	0.0419963939078836	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	CALCA; HTR2A; CXCL12;	GO:0050965~detection of temperature stimulus involved in sensory perception of pain	3	16	18.75	0.0419963939078836	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	SLIT2; BMP4; HEYL; DLL4;	GO:0003180~aortic valve morphogenesis	4	28	14.2857142857143	0.042108963990561	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	F2; OSM; PDGFRA; EPOR; PTPN6; PIK3R5; HCST; PDGFD;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	8	87	9.19540229885057	0.0438021668347398	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	FAM107A; CDKN2D; FHL1; GFI1B; KANK2;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	5	42	11.9047619047619	0.0443729971111908	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	FGFR3; MMP13; MMP16; DLX5;	GO:0001958~endochondral ossification	4	29	13.7931034482759	0.0444559891273538	0.333257670319652	1	1	0.999999988321173	0.999999988321173	1
down	IL33; SCGB1A1; IL20RB; PGLYRP3;	GO:0032689~negative regulation of interferon-gamma production	4	29	13.7931034482759	0.0444559891273538	0.333257670319652	1	1	0.999999988321173	0.999999988321173	1
down	CYP1A1; AQP1; MT1A; MT1M;	GO:0071280~cellular response to copper ion	4	29	13.7931034482759	0.0444559891273538	0.333257670319652	1	1	0.999999988321173	0.999999988321173	1
down	NTRK2; ROS1; KDR; EGFR; EPHA3; EPHA6; FGFR3;	GO:0033674~positive regulation of kinase activity	7	73	9.58904109589041	0.0453011423847702	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	AQP1; AQP5; PDPN;	GO:0006833~water transport	3	17	17.6470588235294	0.0462941436029793	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	CEACAM5; MYOCD; ANKRD2;	GO:0010832~negative regulation of myotube differentiation	3	17	17.6470588235294	0.0462941436029793	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	KRT36; GRHL1; SERPINB13;	GO:0045616~regulation of keratinocyte differentiation	3	17	17.6470588235294	0.0462941436029793	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	BMP7; SIX1; FFAR4;	GO:0090336~positive regulation of brown fat cell differentiation	3	17	17.6470588235294	0.0462941436029793	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	DCLK1; CLDN18; TRIM29;	GO:1900181~negative regulation of protein localization to nucleus	3	17	17.6470588235294	0.0462941436029793	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
up	DLL1; PTCH1; PTCH2;	GO:0001709~cell fate determination	3	17	17.6470588235294	0.0479277301779861	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	CALCA; DBH; GJA4;	GO:0048265~response to pain	3	17	17.6470588235294	0.0479277301779861	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
up	TNFSF11; LCK; SIRPG;	GO:0050870~positive regulation of T cell activation	3	17	17.6470588235294	0.0479277301779861	0.595077492114761	1	1	0.999999991993258	0.999999991993258	1
down	LHX1; LHX3; EGFLAM; TMEFF2;	GO:0008045~motor neuron axon guidance	4	30	13.3333333333333	0.048811398834707	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	EGFR; ADRA2C; ADRA1B; ADRA1D;	GO:0045907~positive regulation of vasoconstriction	4	30	13.3333333333333	0.048811398834707	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	EDN3; GDNF; GBX2; OVOL2; SEMA6D;	GO:0001755~neural crest cell migration	5	44	11.3636363636364	0.0491244887016158	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
down	REN; SDC1; AGXT; ALDH3A1; DUOX1;	GO:0051591~response to cAMP	5	44	11.3636363636364	0.0491244887016158	0.336449314021928	1	1	0.999999988321173	0.999999988321173	1
